MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Names Jeff Clayborne as CFO to Drive Next Phase of Growth
Newton Golf Company (NASDAQ: NWTG) announced the appointment of Jeff Clayborne as Chief Financial Officer, effective immediately. Clayborne brings over 30 years of financial leadership across consumer products, technology, and entertainment, including prior CFO roles…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal Technology
Nutriband (NASDAQ: NTRB) has been granted U.S. patent No. 12,318,492 for its “Abuse and Misuse Deterrent Transdermal Systems,” further strengthening domestic protection for its Aversa(TM) technology. The patent, issued June 3, 2025, enhances the company’s…
-
MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Leads with Vision and Cutting-Edge Gear Amid Golf’s Resurgence
Newton Golf Company (NASDAQ: NWTG) is riding the wave of golf’s renewed popularity, driven by increasing diversity, inclusivity, and innovation within the sport. With more than 47 million Americans engaging in golf activities in 2024, the…
-
MissionIRNewsBreaks – Why Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’
Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. INBS was featured in a recent article that reads, “By utilizing fingerprint sweat analysis,…
-
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 as U.S. Expansion Advances
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, recently attended the RISE25 conference to demonstrate its portable Intelligent Fingerprint Drug Screening System, continuing its push into the U.S.…
-
Soligenix Inc. (NASDAQ: SNGX) Offers Hope on the Horizon with HyBryte(TM) Treatment Targeting CTCL
Cutaneous T-cell lymphoma (“CTCL”) is a rare and debilitating form of non-Hodgkin’s lymphoma that primarily affects the skin, posing both physical and emotional challenges for those diagnosed. With limited treatment options available and no definitive…
-
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, known for treating suicidal bipolar depression and acute suicidal depression, has signed a definitive agreement to acquire Kadima Neuropsychiatry Institute. The Kadima acquisition agreement (not yet closed)…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives Italian Clearance for Option to Acquire Biotech Firm Pincell
Scinai Immunotherapeutics (NASDAQ: SCNI) announced it has received regulatory clearance under Italy’s Golden Power regulation to proceed with its option to acquire 100% of Pincell S.r.l., an Italian biotech company. The approval, issued by Italy’s…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit
CNS Pharmaceuticals (NASDAQ: CNSP) announced that Chief Medical Officer Sandra Silberman, M.D., Ph.D., will present at the Brain Tumor Biotech Summit hosted by Lenox Hill Hospital’s Department of Neurosurgery on June 5, 2025. Her presentation,…
-
Nutriband Inc. (NASDAQ: NTRB) Advances Abuse-Deterrent Buprenorphine Therapy with AVERSA Technology
As the opioid epidemic continues to pose one of the most critical public health crises in the United States and around the world, the need for innovative, safer treatments has never been more urgent. One…
-
MissionIRNewsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Allocate Solar Project Revenue to Bitcoin Treasury Strategy
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has taken its first step toward implementing a Bitcoin treasury strategy by committing net revenue from its 3.79 MW Geddes Solar…
-
MissionIRNewsBreaks – AI-Driven Lending: FAVO Capital Inc. (FAVO) Sets New Standard in Funding Solutions for SMBs
FAVO Capital (OTC: FAVO) is a rapidly growing private credit company dedicated to providing fast, efficient, and personalized funding solutions for small and medium-sized businesses (“SMBs”). “FAVO Capital has more than $138 million in total funding…
-
Nutriband Inc. (NASDAQ: NTRB): A Relentless Mission Rooted in Purpose, Innovation, and Shareholder Value
Serguei Melnik, Founder and President of Nutriband (NASDAQ: NTRB), recently joined The Smart Money Circle Show, where he pulled back the curtain on his no-nonsense approach to biotech entrepreneurship. His grounded tone and unwavering focus on long-term…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Develop 6.9 MW Community Solar Project in Nova Scotia
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Conference
Nutriband (NASDAQ: NTRB) announced that CEO Gareth Sheridan will present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference on Thursday, June 5 at 4 p.m. ET. The session will feature a fireside-style Q&A open to…
-
D-Wave Quantum Inc. (NYSE: QBTS) Launches Commercial Availability of Advantage2(TM) Quantum System
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has officially announced the general availability of its Advantage2 annealing quantum computing system. The launch marks the debut of what…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl Development
Nutriband (NASDAQ: NTRB) reported first-quarter revenue of $667,000, a 63% year-over-year increase driven by expanded kinesiology tape production through its Pocono Pharma subsidiary and growing retail presence at Target, Walmart, Walgreens, and CVS. The company continues…
-
MissionIRNewsBreaks – Innovation in Motion: Massimo Group (NASDAQ: MAMO) Launches Fully Digital Retail Platform
Massimo Group (NASDAQ: MAMO) is entering a new growth phase with the launch of a comprehensive digital retail platform. This move is designed to simplify the purchasing process for its UTVs, ATVs, and mini-bikes, while expanding the…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q1 Revenue Growth Driven by CDMO Contracts, Net Loss Narrows
Scinai Immunotherapeutics (NASDAQ: SCNI) reported first quarter 2025 financial results, posting $586K in revenue, up from zero in the prior-year period, reflecting continued expansion of its CDMO business. R&D expenses declined to $1.3M from $1.6M,…
-
D-Wave Quantum Inc. (NYSE: QBTS) CEO Highlights Revenue Increase, Commercial and Technical Momentum, in Fox Business Interview
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, is seeing momentum build on both the technical and commercial fronts, according to CEO Dr. Alan Baratz, who appeared on…
-
Newton Golf Company Inc. (NASDAQ: NWTG) Releases Financial Report, Business Highlights for Q1 2025
With the launch of its newest shaft family, Newton Golf Company (NASDAQ: NWTG) is seeing triple-figure year-over-year revenue growth, according to the company’s latest financial numbers (https://ibn.fm/hAQWB). The company released its financial report for Q1 2025, noting…
-
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, is advancing its twin strategy of expanding a nationwide mental health clinic network while progressing toward FDA approval of its NMDA-based therapies for suicidal depression and bipolar…
-
MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Regains Nasdaq Compliance Following Strong Q1 Results
Newton Golf Company (NASDAQ: NWTG) announced it has regained compliance with Nasdaq Listing Rule 5550(b)(1) after reporting $6.2 million in stockholders’ equity in its Q1 2025 10-Q filing. The Nasdaq confirmation closes a compliance matter…
-
Newton Golf Company Inc. (NASDAQ: NWTG) Unveils Fast Motion Shaft for Next-Level Play, Game-Changing Innovation
Innovation has long been a driving force behind business growth, market disruption and brand longevity across nearly every sector of the global economy. In the world of sports equipment, few areas are as ripe for…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports 395% Asset Growth in Current Fiscal Year, Focuses on Long-Term Recurring Revenue Strategy
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Highlights Transdermal Pain Solution on BioMedWire Podcast
Nutriband (NASDAQ: NTRB) is featured in the latest episode of The BioMedWire Podcast, part of IBN’s expanding podcast network focused on biotech and pharmaceutical innovation. In a conversation with host Carmel Fisher, Nutriband Co-Founder and CEO…
-
Soligenix Inc. (NASDAQ: SNGX) Innovative Treatment to Combat Bacterial Infection Fills Urgent Need for Alternatives to Antibiotics
In the face of escalating antibiotic resistance, the medical community is urgently seeking alternative treatments for bacterial infections. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is at the forefront of this effort with its development of…
-
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly owned subsidiary HOPE Therapeutics, Inc., a medical and technology-driven company, are expanding their footprint in the mental health care sector with the acquisition of…
-
FAVO Capital Inc. (FAVO): Positioned to Capitalize on Small Business Lending Revival
As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market in the process. With policymakers calling for renewed focus on small…
-
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is preparing for its expected U.S. launch in 2025, as it is progressing through the FDA clearance process for its…
-
MissionIRNewsBreaks – Soligenix Inc.’s (NASDAQ: SNGX) HyBryte(TM) Delivers Strong Results in Rare Cancer Trial
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is leading the way with innovative therapies for rare and difficult-to-treat diseases, particularly early-stage cutaneous T-cell lymphoma (“CTCL”), a rare form of cancer that affects the skin. “Soligenix’s…
-
MissionIRNewsBreaks – Precision Meets Performance: Newton Golf Company Inc.’s (NASDAQ: NWTG) Fitted Shafts Elevate the Game
Newton Golf Company (NASDAQ: NWTG) is revolutionizing golf performance through its high-quality, custom-fitted shafts engineered to match individual swing dynamics. Recognizing the shaft as the “engine” of the club, Newton leverages advanced technology to optimize swing…
-
Nutriband Inc. (NASDAQ: NTRB) Charts Path to Commercialization
In a recent report to shareholders, Nutriband (NASDAQ: NTRB) CEO Gareth Sheridan shared significant company achievements and milestones as well as his expectations for 2025 (https://ibn.fm/9K5zT). At the center of the company’s positive outlook for future is…
-
FAVO Capital Inc. (FAVO): Filling the Financing Gap for Underserved SMBs
With over 5.5 million new business applications filed in the U.S. last year alone, small- to medium-sized businesses (“SMBs”) are thriving, but many are finding themselves underserved by traditional financial institutions. According to recent industry…
-
MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at Wall Street Conference on May 21
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that Founder and CEO Dr. Jonathan Javitt will deliver a company update at the Wall Street Conference on May 21, 2025, in Palm Beach, Florida. NRx…
Search Articles
Latest Articles
- MissionIRNewsBreaks – AI-Driven Energy Demands Highlight Strategic Value of Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Waterberg Project
- Brera Holdings PLC’s (NASDAQ: BREA) Becomes Second Multi-Club Owner in Italy’s Serie B, Signaling Rising Investment Opportunity
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics(TM) Secures Florida Regulatory Clearance to Close Dura Medical Acquisition
- MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures FDA Type C Meeting for AVERSA(TM) Fentanyl Abuse-Deterrent Patch
- MissionIRNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Reports Q1 Fiscal 2026 Net Income of $18.1 Million on $81.3 Million Revenue